Validation of the Health ABC Heart Failure Model for Incident Heart Failure Risk Prediction The Cardiovascular Health Study
Validation of the Health ABC Heart Failure Model for Incident Heart Failure Risk Prediction The Cardiovascular Health Study
复制标题
DOI:
10.1161/circheartfailure.109.904300
复制
发表时间:
2010-07-01
影响因子:
9.7
通讯作者:
Butler, Javed
中科院分区:
文献类型:
--
作者:
Kalogeropoulos, Andreas;Psaty, Bruce M.;Butler, Javed
Background-The recently developed and internally validated Health ABC HF model uses 9 routinely available clinical variables to determine incident heart failure risk. In this study, we sought to externally validate the Health ABC HF model.Methods and Results-Observed 5-year incidence of heart failure, defined as first hospitalization for new-onset heart failure, was compared with 5-year risk estimates derived from the Health ABC HF model among participants without heart failure at baseline in the Cardiovascular Health Study. During follow-up, 400 of 5335 (7.5%) participants developed heart failure over 5 years versus 364 (6.8%) predicted by the Health ABC HF model (predicted-to-observed ratio, 0.90). Observed versus predicted 5-year heart failure probabilities were 3.2% versus 2.8%, 9.0% versus 7.0%, 15.9% versus 13.7%, and 24.6% versus 30.8% for the < 5%, 5% to 10%, 10% to 20%, and > 20% 5-year risk categories, respectively. The Hosmer-Lemeshow chi(2) was 14.72 (degrees of freedom, 10; P=0.14), and the C index was 0.74 (95% CI, 0.72 to 0.76). Calibration and discrimination demonstrated adequate performance across sex and race overall; however, risk was underestimated in white men, especially in the 5% to 10% risk category. Model performance was optimal when participants with normal left ventricular function at baseline were assessed separately. Performance was consistent across age groups. Analyses with death as a competing risk yielded similar results.Conclusions-The Health ABC HF model adequately predicted 5-year heart failure risk in a large community-based study, providing support for the external validity of the model. This tool may be used to identify individuals to whom to target heart failure prevention efforts. (Circ Heart Fail. 2010;3:495-502.)